EBV-TCR-T (YT-E001)

· Fujian Cancer Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBV-TCR-T (YT-E001), covering 2020-08-11 to 2020-08-11. Get the full timeline:

Most recent: Clinical Trial Update: EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC [Phase 2]